CT Findings and Clinical Features of checkpoint Inhibitor-related pneumonitis

Corresponding author: Zheng Jianjun, zhjjnb2@163.com

DOI: 10.12201/bmr.202407.00008

•  

  Abstract: Objective：To explore the CT manifestations and clinical features of checkpoint Inhibitor-related pneumonitis (CIP). Methods: Chest CT images and clinical data of 34 patients with CIP in our hospital were collected to retrospectively analyzed , as well as comparing the differences between lung cancer and other types of cancer patients. Results: Cough (70.59%) and dyspnea (52.94%) were the most common clinical symptoms, and the median time to onset of CIP was 130.5d (54.750,231.250), and it occurred earlier and over a greater time span in the lung cancer group (114.5d, 41.50,281.50) than in the other types of cancer group (144d, 55.75,226.25). Eosinophil count was significantly higher only in the other types of cancer group (p=0.009). After hormonal therapy 18 patients improved, 8 were stable and 8 progressed or even died. CT signs were prevalent in ground glass shadow (70.59%) and solid shadow (76.47%), and the imaging pattern was dominated by organic pneumonia (OP) pattern (16 cases, 47.6%), which was not related to the type of primary tumor, and some of them could show nodular granulomatous reaction.Compared to the lung cancer group, the other types of cancer group was more likely to exhibit symmetrical infiltration (58.33%) distribution . Conclusion: The clinical features of CIP are nonspecific,but CIP was different in eosinophil count and chest CT findings between lung cancer and patients with other malignancies

  Key words: Immune Checkpoint Inhibitors; Pneumonia; Multidetector Computed Tomography

  Submit time: 15 August 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• gaoweiwei, lijialin, liudaijian, wangyulin. Correlational Analysis of Immune-Inflammatory Markers with the Clinical Outcomes of Severe Pneumonia. 2024. doi: 10.12201/bmr.202409.00062

  Shirong Wang, Yalong Dang. The intraocular pressure lowering effects of ROCK inhibitor: the current concepts and perspectives. 2022. doi: 10.12201/bmr.202210.00014

  lin bingjiang, qiu xie, huang hua, xu suling, lu lingyi. Exploring the role of MZT2A in skin cutaneous melanoma based on multiomics data. 2024. doi: 10.12201/bmr.202412.00012

  Yadian Lei, Haiyan Wang. The Impact of the Tumor Immune Microenvironment on T Cell Function: Focusing on the Limitations of ICB and Combined Treatment Strategies. 2024. doi: 10.12201/bmr.202412.00083

  tang zhi xian, Li Ping, 李恒峰, 魏千翔, Xiao Zheng Guang. A review of the use of computerized tongue diagnosis. 2021. doi: 10.12201/bmr.202106.00006

  YE Hongzhou, YUAN Chen. Risk factors of severe pneumonia in children with macrolide-resistant Mycoplasma pneumoniae pneumonia and the construction of prediction model. 2024. doi: 10.12201/bmr.202409.00021

  Li Feifan, Zhang shuitang. Impact of Mixed Infections and Antibiotic Resistance Genes on Clinical Features in Children with Mycoplasma pneumoniae Pneumonia. 2024. doi: 10.12201/bmr.202412.00025

  JIA Bei, DAI Yuanyuan. Sintilimab-induced Diabetes Ketoacidosis with multiple organ immune related adverse reactions:A Clinical Case. 2024. doi: 10.12201/bmr.202411.00022

  WANG Guangyan, NAN Shuang. Mendelian Randomization Study on Cervical Cancer and Immune Cell Phenotypes. 2024. doi: 10.12201/bmr.202412.00050

  Zhang Lina, Zhang qiuyue, Li Zhen, Tian Jia. Changes and Significance of Coagulation Function Indicators in Elderly Patients with Severe Pneumonia. 2024. doi: 10.12201/bmr.202411.00035

• ID	Submit time	Number	Download
  1	2024-07-05	bmr.202407.00008V1	Download

• Public  Anonymous  To author only Submit Comments